Drugs / TEZ/IVA
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03227471 | Jan 2017 → Mar 2018 | cystic fibrosis | Vertex Pharmaceuticals Incorporated | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TEZ/IVA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03227471 ↗ |
| Route | Oral | “TEZ/IVA fixed-dose combination for oral administration.” NCT03227471 ↗ |